Optimum AI: The Future of DeFi, Now Enabled Via Text-Based Trading on WhatsApp and Telegram
25 mai 2024 13h56 HE | Optimum AI
New York, NY, May 25, 2024 (GLOBE NEWSWIRE) -- In a move that is set to reshape the world of decentralized finance, Optimum AI has launched a revolutionary text-based trading platform that...
metfi.png
Marine Moguls ERC-404 Launch with $2.9 Million in Prizes for Token Holders!
25 mai 2024 08h00 HE | Marine Moguls by MetFi
Seoul, South Korea, May 25, 2024 (GLOBE NEWSWIRE) -- Marine Moguls has officially launched on the revolutionary ERC-404 protocol, ushering in a new era of digital asset innovation.  ...
ValueZone logo.PNG
ValueZone CEO Highlights Strategy Behind Its Top-Rated Trading Platform
25 mai 2024 08h00 HE | ValueZone
London, England, May 25, 2024 (GLOBE NEWSWIRE) -- During a recent industry conference, Adam Carl Waldman, CEO of ValueZone, detailed the strategies that have positioned ValueZone as one of the...
crydit.png
Crydit Unveils Revolutionary Unlimited Crypto Card Redefining Crypto Payments
25 mai 2024 07h00 HE | Crydit
London, England, May 25, 2024 (GLOBE NEWSWIRE) -- Crydit, with the vision of “Pay Everything,” announces the official launch of the first Unlimited Crypto Card in the industry. Crydit is poised to...
NOVARTIS logo.jpg
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio
25 mai 2024 06h15 HE | Novartis Pharma AG
In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction...
NOVARTIS logo.jpg
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo
25 mai 2024 06h00 HE | Novartis Pharma AG
Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical...
Academic Labs Launches Second Airdrop, AMA Explores AI's Role in the New Era of Education
24 mai 2024 20h35 HE | Academic Labs
SINGAPORE, May 24, 2024 (GLOBE NEWSWIRE) -- Recently, Academic Labs has announced the launch of its second airdrop event, HomeComing, starting on May 23 at their official website acad.live. This...
Patient Care
Halo Dental Technologies Showcase Their Digital Mirror at Montreal-based JDIQ Annual Conference
24 mai 2024 19h39 HE | Halo Dental Technologies
MONTREAL, May 24, 2024 (GLOBE NEWSWIRE) -- Halo Dental Technologies, the developer behind the much-anticipated Halo Digital Mirror, is bringing the innovation to Journées Dentaires Internationales du...
Launch Ads AI
Launch Cart Announces Revolutionary AI Ads Platform, LaunchAds.ai, Showing 40x Faster Ad Launch and 105% Higher Click-Through Rates
24 mai 2024 19h20 HE | Launch Cart
San Diego, CA, May 24, 2024 (GLOBE NEWSWIRE) -- Launch Cart, a leading eCommerce solutions provider, proudly announces early results from its cutting-edge AI ads platform, LaunchAds.ai. This...
PurposeLogos-K_RGB.png
Purpose Investments Inc. Announces Final May 2024 Distribution Rate for Cash and Money Market ETFs, Updates Ex-Distribution Date for Purpose Emerging Markets Dividend Fund, Purpose International Dividend Fund, and Big Banc Split Corp, and Provides an Update to T+1 Settlement Schedule
24 mai 2024 19h00 HE | Purpose Investments Inc.
TORONTO, May 24, 2024 (GLOBE NEWSWIRE) -- Purpose Investments Inc. announced today the final May 2024 distribution rates for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash...